Amazon launches AI research tool to speed early-stage drug discovery

Amazon’s cloud unit on Tuesday launched Amazon Bio Discovery, an artificial intelligence application designed to speed early-stage drug discovery by allowing scientists to run complex computational workflows without writing code.

Drugmakers and technology companies have stepped up efforts to use AI to accelerate drug development.

Amazon Web Services said in a blog post ‌that Amazon ⁠Bio ⁠Discovery gives researchers access to a library of specialized biological foundation models that can generate and evaluate potential drug molecules, along with an AI agent that helps users select models, set parameters and interpret results.